Medical Suppliers & Manufacturers In Europe

Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins to improve microbial fermentation. Our team of scientists works in different academic laboratories and our R&D programs involve partners from ...

Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients ...

CicaLux Energized Scar-Care is a combination therapy device designed to help prevent or improve hyper-pigmented, hypertrophic (raised) and/or keloid scars resulting from incisional ...

Founded in 2012 at University of Manchester, Gelmetix is a UK medtech company focused on treating chronic lower back pain caused by the degeneration of the intervertebral discs. Gelmetix’s polymer gel technology also has the potential to be adapted ...

We are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses ...

Blueback markets a medical device that makes it easy and quick to assess the tone of the deep muscles. True innovation, Blueback Physio, supports healthcare professionals in this difficult but essential assessment in their ...

Esma has its seat in Maasmechelen (Belgium) in the middle of the Euregio. At this place we fabricate our own product such as counterbalances and spare parts as a supplier. Esma is a family business and has grown into a flexible company with modern ...

At BiomimX we develop clinically relevant and fast responsive technology driven solutions tailored made to fit applications in Big Diseases. Integrating 3D cell culture and mechanical stimulation, BiomimX proposes the next generation of beating ...

Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...

Our patent protected platform combines microfluidic processes, electroanalytical and immunochemical sensors, with the output read and interpreted by a handheld reader. This miniaturisation offers quantitative, near patient results. Software in the ...

RaySearch® is advancing cancer treatment through pioneering software. Software has unlimited potential, and it is now the driving force for innovation in oncology. Medical science never stands still and neither does RaySearch. We work in close ...

We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the ...

Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...

TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients ...

With nearly 15 years of experience, Cap Actuel is constantly looking for relevant solutions and technologies to meet the specific expectations of professionals concerned with offering quality services adapted to the main issues of beauty, health and ...

Founded in 2016 by a group of experienced engineers and bio-informaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure ...

Originally founded in 1998 as an independent entity by Horst Lindhofer, we have assisted in the preclinical and clinical development of all Triomab® antibodies that are under development or received market approval, including that of Removab®, the ...

Originally conceived in the 1990’s, Advanced Healthcare Technology Ltd. (‘AHT’) was formed around the concept of a new lightweight solution to the problem of transporting neonatal infants safely in vehicles. As the norm, heavy full-featured ...

Curadigm is an early-stage company focused on shifting the paradigm of therapeutic clearance, bioavailability, and efficacy to improve treatment outcomes for millions of patients. Curadigm was spun-off from Nanobiotix, a late-stage clinical company, ...

We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...